Journal
EUROPEAN UROLOGY
Volume 53, Issue 5, Pages 1013-1020Publisher
ELSEVIER SCIENCE BV
DOI: 10.1016/j.eururo.2007.09.034
Keywords
English botulinum toxin; type A; multiple injection; neurogenic detrusor; overactivity; spinal cord lesion
Categories
Ask authors/readers for more resources
Objective: Determine long-term effect of English botulinum neurotoxin type A (BoNTA; Dysport (R)) for refractory neurogenic detrusor overactivity (NDO) for possible reduction of BoNTA efficacy after repeated injections. Methods: Between 1999 and 2005, 199 patients with spinal cord lesions with refractory NDO were treated with Dysport. All patients underwent a clinical examination, urinalysis, and videourodynamic study at baseline and at 3, 6, and 12 mo after each treatment, as well as a visual analogue scale (VAS) assessment and a bladder diary checked for 1 wk before each visit. We used 1000, 750, 500 IU BoNTA at the beginning of our experience, and thereafter we mainly used 750 IU. Outcome measures included frequency of urge urinary incontinence (Incontinence Episode Frequency [IEF] test); urodynamic parameters including maximum cystometric bladder capacity (MCBC), reflex volume (RV), bladder compliance (BC); number of pads/condoms; antimuscarinic drug consumption; short- and long-term side-effects; and quality of life measured with VAS. Results: No statistically significant differences were found in efficacy duration with the three Dysport doses (p = 0.5274). The difference between the intervals of injections was not statistically significant (p = 0.2659). MCBC, RV, and BC improved significantly after treatment compared with baseline values (p < 0.001) and there were no statistically significant differences after each retreatment or regarding Dysport dose (p > 0.05). There was a significant improvement in patient satisfaction after each retreatment as expressed on the VAS (p < 0.001). There was a significant reduction in IEF score and pads/ condoms use in the first 4 wk after each treatment (p < 0.0001). Conclusion: After repeated injections the effect of BoNTA remained constant. (c) 2007 European Association of Urology. Published by Elsevier B.V. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available